BMEZ: Removal Of Options Should Improve Performance (Rating Upgrade)

2026-05-28 05:40:03 ET

Overview

The BlackRock Health Sciences Term Trust ( BMEZ ) offers investors a way to get instant diversification across a portfolio of health care companies. However, I issued a sell rating at the time of my last coverage because of its poor NAV growth and underperformance against peers. However, the fund has released an updated annual report, and there may be a renewed growth catalyst over the next few years. Therefore, I wanted to take a more focused look at the fund and reassess its current value proposition for investors....

Read the full article on Seeking Alpha

For further details see: